Research in the BioTherapeutics research programme is aimed at a smoother and speedier transition from preclinical research to pharmacological interventions, and the delivery of drugs in the human body by use of small molecules and biologics.
- Johan Kuiper
Our work aims at the innovative biopharmaceutical concepts to intervene in auto-immune-like disorders, using biologics such as vaccines and therapeutic proteins.
We strive for an integration of our experimental in-vitro and in-vivo data, in order to develop quantitative systems biology models of health and disease states, thus enabling us to better predict efficacy and drug safety. A special aim lies in finding new targets in immune based diseases such as atherosclerosis.